Biotechnology firm Novacyt has said it could axe about 40% of its workforce as part of a major restructuring.
The molecular diagnostics company, which has a base in Manchester, launched a consultation process on Monday.
Biotechnology firm Novacyt has said it could axe about 40% of its workforce as part of a major restructuring.
The molecular diagnostics company, which has a base in Manchester, launched a consultation process on Monday.